FOLFOXIRI plus panitumumab as first-line treatment of RAS wild-type metastatic colorectal cancer: the randomized, open-label, phase II VOLFI study (AIO KRK0109) - Modest, D P; Martens, U M; Riera-Knorrenschild, J (J Clin Oncol, 2019)